Counterfeit drugs and medical devices are a pervasive problem for the pharmaceutical industry and for consumers. It’s an issue that affects countries around the world, according to SICPA, a firm that has developed secured identification and traceability solutions for companies to assess and manage risks to their products.
“In places like Sub-Saharan Africa, 30-40% of all medicines are believed and documented to be counterfeit,” SICPA’s VP Richard Einhorn told Drug Delivery Business News.
Get the full story at our sister site, Drug Delivery Business News.